Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORKA: Epacadostat and Pembrolizumab in Head and Neck Cancer
NCT03463161Phase 2Terminated
- Sponsor
- University of Chicago
- Start
- Mar 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epacadostat in head and neck squamous cell carcinoma (HNSCC), sponsored by University of Chicago. Started Mar 2018; status: terminated.
02
Drugs
epacadostat
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT03463161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03463161.